RLAY - Relay Therapeutics, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.38
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.50
DETAILS
HIGH:
$14.00
LOW:
$13.00
MEDIAN:
$13.50
CONSENSUS:
$13.50
UPSIDE:
47.06%
Market Cap:
1.59B
Volume:
1,282,110
Avg Volume:
2,223,623
52 Week Range:
1.775-9.54
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.62
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
259
IPO Date:
2020-07-16
EPS (TTM):
-2.36
P/E Ratio:
-1.74
Revenue (TTM):
10.01M
Total Assets:
871.30M
Total Debt:
48.50M
Cash & Equiv:
124.29M
Rev Growth (5Y):
-41.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-47.0%
Debt/Equity:
0.06
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.43 | $-0.39 | -10.3% | — | $5.0M | — |
| 2025-08-07 | $-0.41 | $-0.49 | +16.3% | $677000 | $14290 | +4637.6% |
| 2025-05-05 | $-0.46 | $-0.50 | +8.0% | $7.7M | $3.8M | +104.1% |
| 2025-02-26 | $-0.45 | $-0.57 | +21.1% | — | $5.5M | — |
| 2024-11-06 | $-0.63 | $-0.77 | +18.2% | — | $66670 | — |
| 2024-08-06 | $-0.69 | $-0.73 | +5.5% | — | $80000 | — |
| 2024-05-02 | $-0.62 | $-0.70 | +11.4% | $10.0M | $30000 | +33256.7% |
| 2024-02-22 | $-0.67 | $-0.76 | +11.8% | $1000 | $130000 | -99.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 10.01M | 25.55M | 1.38M | 3.03M | 82.65M | 0 | 0 |
| Net Income | (337.71M) | (341.97M) | (290.51M) | (363.87M) | (52.41M) | (66.50M) | (48.78M) |
| EPS | -2.36 | -2.79 | -2.59 | -3.82 | -2.56 | -15.53 | -19.63 |
| Total Assets | 871.30M | 843.98M | 1.10B | 1.01B | 799.83M | 393.07M | 428.61M |
| Total Debt | 48.50M | 53.47M | 57.74M | 22.90M | 24.42M | 24.83M | 178,000 |
| Cash & Equivalents | 124.29M | 143.74M | 998.92M | 280.12M | 447.65M | 41.95M | 421.50M |
| Operating Cash Flow | (249.11M) | (300.32M) | (229.49M) | (74.41M) | (102.49M) | (66.13M) | (44.13M) |
| Free Cash Flow | (251.12M) | (304.44M) | (238.55M) | (77.88M) | (104.42M) | (74.14M) | (45.82M) |
| FCF per Share | -1.76 | -2.48 | -2.13 | -0.82 | -1.16 | -17.32 | -18.44 |
| Book Value | 777.79M | 752.00M | 950.22M | 897.81M | 763.29M | (180.44M) | (110.93M) |
| Cash & ST Investments | 781.32M | 750.09M | 998.92M | 958.07M | 678.06M | 355.82M | 421.50M |
| ROC Equity | -0.43 | -0.45 | -0.31 | -0.41 | -0.07 | N/A | N/A |